findmyKOL

Goetz Kloecker, MD

Enriched profile

Professor of Medicine, University of Louisville School of Medicine; Director, Medical Oncology/Hematology Fellowship Program (gratis faculty status since 2020); also Co-Director of Thoracic Oncology, St. Elizabeth Healthcare (Edgewood, KY) · University of Louisville

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Louisville, KY · Southeast · United StatesSpecialtyHematology / OncologyFocusLung Cancer (NSCLC/SCLC)
Active KOLfindmyKOL type: EliteLatest publication2024Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Goetz Kloecker is Professor of Medicine, University of Louisville School of Medicine; Director, Medical Oncology/Hematology Fellowship Program (gratis faculty status since 2020); also Co-Director of Thoracic Oncology, St. Elizabeth Healthcare (Edgewood, KY) at University of Louisville. OpenAlex indexes 193 publications with 4,786 citations (h-index 32); ClinicalTrials.gov lists 11 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Goetz Kloecker, MD, is Professor of Medicine, University of Louisville School of Medicine. The public record shows 193 publications with 4,786 citations (h-index 32), centered on Lung Cancer (NSCLC/SCLC). It also documents an investigator role on 11 registered clinical trials, industry payments reported by 64 companies.

  • Top research focus: Lung Cancer (NSCLC/SCLC)
  • 11 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 64 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Cancer (NSCLC/SCLC)7 trialsSmall Cell Lung Carcinoma4 trialsNeoplasm Metastasis1 trialCarcinoma, Small Cell1 trialThrombocytopenia1 trialCytopenia1 trialPain1 trial

Research focus

OpenAlex concept fingerprint
Lung Cancer (NSCLC/SCLC)

Drugs & molecules

across trials, industry payments and publications
Libtayogeneric · CemiplimabClinical trials—Industry payments92Publications—Keytrudageneric · PembrolizumabClinical trials—Industry payments43Publications—Opdivogeneric · NivolumabClinical trials—Industry payments42Publications—Zepzelcageneric · LurbinectedinClinical trials—Industry payments39Publications—Enhertugeneric · TrastuzumabClinical trials—Industry payments32Publications—Imfinzigeneric · DurvalumabClinical trials—Industry payments27Publications—Krazatigeneric · AdagrasibClinical trials—Industry payments25Publications—Tagrissogeneric · OsimertinibClinical trials—Industry payments25Publications—Lumakrasgeneric · SotorasibClinical trials—Industry payments23Publications—Datrowaygeneric · Datopotamab deruxtecanClinical trials—Industry payments20Publications—Cablivigeneric · CaplacizumabClinical trials—Industry payments17Publications—Fabhaltageneric · IptacopanClinical trials—Industry payments14Publications—

Works with

trial sponsors and companies reporting payments
Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments84AstraZeneca Pharmaceuticals LPClinical trials—Industry payments75E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments60Daiichi Sankyo Inc.Clinical trials—Industry payments50Novartis Pharmaceuticals CorporationClinical trials—Industry payments48Merck Sharp & Dohme LLCClinical trials—Industry payments45Jazz Pharmaceuticals Inc.Clinical trials—Industry payments42Genzyme CorporationClinical trials—Industry payments36Amgen Inc.Clinical trials—Industry payments32Mirati Therapeutics, Inc.Clinical trials—Industry payments25Incyte CorporationClinical trials—Industry payments18Pfizer Inc.Clinical trials—Industry payments18Genentech USA, Inc.Clinical trials—Industry payments16EMD Serono, Inc.Clinical trials—Industry payments14Janssen Biotech, Inc.Clinical trials—Industry payments12Abbvie Inc.Clinical trials—Industry payments10University of LouisvilleClinical trials10Industry payments—Celgene CorporationClinical trials—Industry payments8Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments7Gilead Sciences, Inc.Clinical trials—Industry payments7Array Biopharma IncClinical trials—Industry payments6Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments6Stemline Therapeutics Inc.Clinical trials—Industry payments6Adaptive Biotechnologies CorporationClinical trials—Industry payments5BeiGene USA, Inc.Clinical trials—Industry payments5Novocure Inc.Clinical trials—Industry payments5Puma Biotechnology, Inc.Clinical trials—Industry payments5Recordati_Rare_Diseases_Inc.Clinical trials—Industry payments5Adc Therapeutics America, Inc.Clinical trials—Industry payments3Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments3

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
193publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,786citations

Total citations across indexed works.

32h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials ↓
64companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:

All 11 trial records: search, sort and filter.Explore →

Industry payments

Updated 14 Oct 2026

64 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 132 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    30%
    Corticosteroid30%
    Dexamethasone100%
    Part D≥17 patients

  • Nervous system

    30%
    Phenothiazine30%
    Prochlorperazine Maleate100%
    Part D≥15 patients

  • Cancer & immunology

    21.7%
    Kinase inhibitor21.7%
    Tagrisso100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 0 publications: search, sort and filter.Explore →

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/goetz-kloecker-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Goetz-Kloecker

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/UofLHealthBCC/posts/dr-goetz-kloecker-medical-oncologist-and-director-of-our-lung-cancer-multidiscip/10155689800085146

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • LinkedIn

    linkedin.com/posts/kentucky-medical-association_kma-member-goetz-kloecker-md-fellowship-activity-7267915745496285184-0DpU

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • LinkedIn

    linkedin.com/posts/uofl-physicians_welcome-back-dr-goetz-kloecker-dr-kloecker-activity-6963854372355112960-R-iI

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • Other

    m.soundcloud.com/kentucky-onehealth/dr-goetz-h-kloecker-on-lung-cancer

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →m.soundcloud.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MBA

    Morehead State University

    2005
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →louisville.edu ↗
  • Fellowship

    Hematology/Oncology, University of Louisville

    2003
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uoflhealth.org ↗
  • M.S.P.H.

    University of Louisville

    2002
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uoflhealth.org ↗
  • Residency

    Internal Medicine, University of Erlangen/Nuremberg and Free University of Berlin, completed at University of Louisville

    1997
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uoflhealth.org ↗
  • M.D.

    Technical University of Munich

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uoflhealth.org ↗
  • B.S.

    University of Regensburg

    1986
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uoflhealth.org ↗
  • Board Certifications (ABIM): Internal Medicine

    Medical Oncology, Hematology, Palliative Care

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uoflhealth.org ↗
  • FACP (Fellow, American College of Physicians)
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →accc-cancer.org ↗

Editorial & leadership roles

journal and society appointments
  • Director-at-Large

    Kentucky Society of Clinical Oncology (KYSCO) Board of Directors, 2026-2027

    2027
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kysco-oncology.org ↗
  • Professor of Medicine

    University of Louisville School of Medicine, Department of Medicine (Division of Medical Oncology & Hematology)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uoflhealth.org ↗
  • Director

    Medical Oncology/Hematology Fellowship Program, University of Louisville

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uoflhealth.org ↗
  • Director of Thoracic Oncology

    UofL Health – Brown Cancer Center (historical/prior role per MD-Update feature)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →md-update.com ↗
  • Co-Director of Thoracic Oncology

    St. Elizabeth Healthcare, Edgewood, KY

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →accc-cancer.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.